BMVC is a promising anti‐cancer drug candidate which binds in low nM range, but it lacks selectivity for c‐MYC over other G4s.[43] However, the reported solution NMR structure of the BMVC‐c‐MYC22 complex can be used for targeted ligand design. Here, MYC is linked to cancer.